- Home
- HNI vs ZLAB Comparison
HNI vs ZLAB Comparison
Compare HNI & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNI | ZLAB |
|---|---|---|
| Founded | 1944 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | HNI | ZLAB |
|---|---|---|
| Price | $51.76 | $19.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $70.00 | $51.52 |
| AVG Volume (30 Days) | 485.6K | ★ 800.8K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | ★ 16.22 | N/A |
| EPS | ★ 2.98 | N/A |
| Revenue | ★ $2,593,100,000.00 | $441,629,000.00 |
| Revenue This Year | $6.52 | $26.16 |
| Revenue Next Year | $127.46 | $30.62 |
| P/E Ratio | $17.40 | ★ N/A |
| Revenue Growth | 1.15 | ★ 24.14 |
| 52 Week Low | $38.04 | $15.96 |
| 52 Week High | $53.29 | $44.34 |
Technical Indicators
Market Signals| Indicator | HNI | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 77.98 | 57.82 |
| Support Level | $51.51 | $15.96 |
| Resistance Level | $52.79 | $20.00 |
| Average True Range (ATR) | 1.00 | 0.74 |
| MACD | 0.26 | 0.27 |
| Stochastic Oscillator | 82.62 | 75.62 |
Price Performance
Historical ComparisonAbout HNI HNI Corporation
HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.